Encompass Health Corporation (EHC)
NYSE • Healthcare
Last close at September 9, 2026 at 20:00 UTC
Metrics Over Time
Where the Money Goes
Q2 2026In plain terms: out of every $100 in revenue, Encompass Health Corporation keeps $10 as net profit.
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings
Oct 28
in 48 daysQ4 2026% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS
Encompass Health beat expectations on both the top and bottom line based on preliminary results for the second fiscal quarter of 2026, reported Aug. 5. Revenue rose 9.6% to about $1.6 billion and edged the $1.57 billion consensus by 1.7%, while operating margin held near 18% and operating income came in at about $288 million; EPS of $1.55 topped the $1.48 estimate by 4.7% and was up 10.7% from $1.40 a year ago. Net income climbed 8.3% to about $154 million from $142.1 million a year earlier, operating cash flow was $595.7 million, and the company repurchased about $145.8 million of stock while paying $39.2 million in dividends. Next-period consensus calls for EPS of $1.39 on revenue of $1.59 billion.
About Encompass Health Corporation
Encompass Health Corporation operates post-acute healthcare services on the NYSE under the ticker EHC, centered on rehabilitation hospitals, home-based clinical care, and hospice. In FY2025, the company generated $5.9 billion in revenue. It works within the healthcare services market, specifically facility-based and in-home care for patients recovering from illness or injury.
Today's Snapshot
EHC opened 0.8% higher at 122.49, in line with a flat sector.
Trading Volume
Below 10d avg (693.2K)
77K
vs S&P 500 Today
Outperforming Market
+0.61%
Updated: September 10, 2026 at 14:53 UTC
Technical Indicators
All signalsHide signals
- EMA (5 indicators)$112.10 - $121.67Buy
- RSI (14)61.31Neutral
- Stochastic %K (14, 3, 3)62.61Neutral
- MACD Level (12, 26)1.47Neutral
Peers & Related Assets
Get premium market insights delivered directly to your inbox.